Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hangkai Huang

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Experimental & Molecular Medicine|April 30, 2025
Histidine triad nucleotide-binding protein 2 attenuates metabolic dysfunction-associated steatotic liver disease through NAD<sup>+</sup>-dependent sirtuin-3 activationQinqiu Wang, Yanjun Guo, Shenghui Chen, et al.
The Journal of Biological Chemistry|February 12, 2025
Amyloid precursor protein promotes MASH progression by upregulating death receptor 6-mediated hepatocyte apoptosisYanjun Guo, Hangkai Huang, Ling Yang, et al.
Msystems|October 20, 2025
Microbial changes resulting from VSG attenuate MASLD by modulating bile acid metabolism and the intestinal FXR-FGF19 axisYi Xia, Jinpu Yang, Shixian Lu, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Experimental & Molecular Medicine|April 30, 2025
Histidine triad nucleotide-binding protein 2 attenuates metabolic dysfunction-associated steatotic liver disease through NAD<sup>+</sup>-dependent sirtuin-3 activationQinqiu Wang, Yanjun Guo, Shenghui Chen, et al.
The Journal of Biological Chemistry|February 12, 2025
Amyloid precursor protein promotes MASH progression by upregulating death receptor 6-mediated hepatocyte apoptosisYanjun Guo, Hangkai Huang, Ling Yang, et al.
Msystems|October 20, 2025
Microbial changes resulting from VSG attenuate MASLD by modulating bile acid metabolism and the intestinal FXR-FGF19 axisYi Xia, Jinpu Yang, Shixian Lu, et al.
Pageof 4